GL1X · GenesisL1 explorer

MolNFT v1 · #184049 · protein

Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide

7OBS · 14-3-3 protein sigma: “Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide”. X-ray diffraction, 2 ligands (MG, CA), 2 pockets (best druggability 0.51). MolNFT v1 #184049 on GenesisL1: 3D structure, binding sites…

PDB
7OBS
Type
protein
Length
242 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
14-3-3 protein sigma; Receptor-interacting SERINE/THREONINE-protein kinase 2
EC
2.7.11.1, 2.7.10.2
UniProt
P31947, O43353
Ligands
MG, CA
Pockets
2 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 78% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A14-3-3 protein sigmaprotein23680% helix, 0% strandP31947
BReceptor-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 2.7.10.2)protein60% helix, 0% strandO43353

Ligands and binding sites

  • MG · Magnesium ion · metal · 3 copies · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1880.510.8318empty
2690.340.7615empty

Interfaces

1 interface between chains.

  • A–B · 575 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (oxidation, phosphorylation).

Compared structures

  • 7OBS · Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide · the same entry in another collection · chain A against A, TM-score 1.00
  • P31947 · AlphaFold monomer V2.0 prediction for 14-3-3 protein sigma (P31947) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.